Has clinical activity in paediatric neurology changed in the past 11 years?

B Martínez Menéndez1, E Escolar Escamilla1, A Pinel González1

  • 1Unidad de Neurología Pediátrica, Sección de Neurología, Hospital Universitario de Getafe, Getafe, Madrid, España.

Insights

Demand for paediatric neurology care has significantly increased, driven by a rise in neurodevelopmental disorders like attention deficit-hyperactivity disorder (ADHD). This trend highlights ADHD

Area of Science:

  • Neurology
  • Pediatrics
  • Public Health

Background:

  • Paediatric neurology (PN) care demand is perceived to have risen over the last decade.
  • Consultation reasons in PN have also evolved.
  • A registry study in 2002 provides a baseline for comparison.

Purpose of the Study:

  • To profile the demand for paediatric neurology care in 2013.
  • To compare 2013 PN care demand with data from 2002.
  • To identify changes in reasons for PN consultations.

Main Methods:

  • A prospective registry of PN healthcare activities was conducted in 2013.
  • Data from 2013 were compared with a prospective registry study from 2002.
  • The study was performed at Hospital Universitario de Getafe.

Main Results:

  • PN visits increased by 52.46% (1,300 in 2002 to 1,982 in 2013).
  • Visits per 1,000 children rose by 76.32% (32.6 to 57.48).
  • Attention deficit-hyperactivity disorder (ADHD) became the most frequent diagnosis (27.6% in 2013 vs. 8.1% in 2002).
  • Headache remained the most common initial visit reason (32.1%), followed by ADHD (19.1%).
  • Epilepsy was the leading diagnosis for hospitalized patients (30.3% in 2013).

Conclusions:

  • Paediatric neurology is predominantly an outpatient service with substantial recent growth.
  • The increase in PN demand is primarily attributed to neurodevelopmental disorders, particularly ADHD.
  • The impact of ADHD on paediatric neurology is comparable to dementia in general neurology.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
392
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
513
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895